M. Cengiz Et Al. , "Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis," CLINICAL LABORATORY , vol.67, no.3, pp.804-820, 2021
Cengiz, M. Et Al. 2021. Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis. CLINICAL LABORATORY , vol.67, no.3 , 804-820.
Cengiz, M., Yilmaz, G., & ÖZENİRLER MAYER, S., (2021). Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis. CLINICAL LABORATORY , vol.67, no.3, 804-820.
Cengiz, Mustafa, GÜLDAL ESENDAĞLI, And SEREN ÖZENİRLER MAYER. "Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis," CLINICAL LABORATORY , vol.67, no.3, 804-820, 2021
Cengiz, Mustafa Et Al. "Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis." CLINICAL LABORATORY , vol.67, no.3, pp.804-820, 2021
Cengiz, M. Yilmaz, G. And ÖZENİRLER MAYER, S. (2021) . "Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis." CLINICAL LABORATORY , vol.67, no.3, pp.804-820.
@article{article, author={Mustafa Cengiz Et Al. }, title={Serum Biglycan as a Diagnostic Marker for Non-Alcoholic Steatohepatitis and Liver Fibrosis}, journal={CLINICAL LABORATORY}, year=2021, pages={804-820} }